{"line": {"P": {"question": {"id": "8107da77-5d36-4580-b6df-00f548ba4fd6", "title": "Will the CMA announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK officially announces the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. Completion must be confirmed through an official CMA announcement or reported by at least two major news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not announce the completion of such an investigation by this date, or if the investigation is still ongoing, the question resolves as NO.", "resolution_date": "2024-07-31T23:59:59Z", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30T23:59:59Z", "url": null, "metadata": {}, "resolution": false}, "forecast": {"prob": 0.5263621852500315, "metadata": [{"name": "P", "elicited_prob": 0.5746939591751171, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.5595753979938229, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.6127433773037299, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.65, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "87cf119c-6f7a-4e05-be02-8d4c44b7a0f3", "title": "Will the CMA not announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK does not officially announce the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. Completion must not be confirmed through an official CMA announcement or reported by at least two major news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does announce the completion of such an investigation by this date, or if the investigation is still ongoing, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "7d719c83-1983-44d4-b720-5e56de3b4339", "title": "Is the CMA expected to declare the conclusion of a significant pharmaceutical pricing inquiry by July 2024?", "body": "This inquiry will be considered resolved as YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) officially declares that its investigation into pharmaceutical pricing practices involving at least five major firms has concluded. Confirmation of completion must come through an official announcement from the CMA or be reported by at least two prominent news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not announce the conclusion of this investigation by the specified date, or if the investigation remains active, the inquiry will resolve as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.6, "elicitation_metadata": null}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "8b85fcdc-afc8-4837-800a-20e9da19a04b", "title": "Will the CMA not announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK does not officially announce the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. Completion must not be confirmed through an official CMA announcement or reported by at least two major news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does announce the completion of such an investigation by this date, or if the investigation is still ongoing, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3121185996084903, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.3, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "3fc681bf-7ed1-478e-9126-48dad23e1ca2", "title": "Will the CMA announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK officially announces the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. Completion must be confirmed through an official CMA announcement or reported by at least two major news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not announce the completion of such an investigation by this date, or if the investigation is still ongoing, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "cac50f32-1913-4c99-bd80-0cf400ebf8d8", "title": "Will the CMA refrain from declaring the conclusion of a significant inquiry into pharmaceutical pricing before July 2024?", "body": "This inquiry will be considered YES if, by July 31, 2024, the UK\u2019s Competition and Markets Authority (CMA) has not made an official statement regarding the conclusion of its investigation into pricing practices in the pharmaceutical sector involving at least five major firms. The conclusion must not be verified through an official announcement from the CMA or reported by at least two prominent news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). Conversely, if the CMA does declare the conclusion of such an investigation by this date, or if the investigation remains active, the inquiry will be considered NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3, "elicitation_metadata": null}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "d1fbfaff-5eda-48b3-b303-763abbd8a67c", "title": "Will the Competition and Markets Authority declare the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will resolve as YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) publicly states that it has concluded its investigation into the pricing practices of at least five major pharmaceutical companies. The conclusion must be validated through an official announcement from the CMA or reported by a minimum of two leading news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA fails to announce the conclusion of this investigation by the specified date, or if the inquiry remains active, the resolution will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4636472856082493, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.35, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "e2515d7e-7602-43bf-bf02-001b3f0a1492", "title": "Will the Competition and Markets Authority not declare the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will resolve as YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) does not publicly state that it has concluded its investigation into the pricing practices of at least five major pharmaceutical companies. The conclusion must not be validated through an official announcement from the CMA or reported by fewer than two leading news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA announces the conclusion of this investigation by the specified date, or if the inquiry is concluded, the resolution will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "5e5daa33-8a21-4237-bf31-2f6d118ac4b1", "title": "Will the CMA announce the end of a major investigation into drug pricing by July 2024?", "body": "This investigation will be deemed as resolved with a YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) officially declares that it has finished its inquiry into the pricing strategies of at least five prominent pharmaceutical firms. This conclusion must be confirmed through an official statement from the CMA or covered by at least two major news outlets (like Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not make an announcement regarding the conclusion of this inquiry by the given date, or if the investigation is still ongoing, the outcome will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}]}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "2f59295d-a53e-4c65-83f4-356708ee54f2", "title": "Will the CMA not announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK does not officially announce the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. Completion must not be confirmed through an official CMA announcement or reported by at least two major news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA announces the completion of such an investigation by this date, or if the investigation is still ongoing, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.39928024721083555, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.43631624107272954, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "773aa429-6086-4020-8fa3-d78e2cdfa650", "title": "Will the CMA announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK officially announces the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. Completion must be confirmed through an official CMA announcement or reported by at least two major news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not announce the completion of such an investigation by this date, or if the investigation is still ongoing, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.35, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "5b747c29-a149-4328-a23f-2e7950868739", "title": "Will the CMA fail to declare the conclusion of a significant investigation into pharmaceutical pricing before July 2024?", "body": "This inquiry will be answered with YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) does not make an official statement regarding the conclusion of its investigation into the pricing practices of at least five major pharmaceutical companies. The investigation's conclusion must not be verified through an official announcement from the CMA or reported by at least two prominent news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA makes an announcement regarding the conclusion of this investigation by the specified date, or if the investigation remains in progress, the answer will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.35, "elicitation_metadata": null}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "911eed92-0a24-4791-b996-117f94e47f30", "title": "Will the CMA announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK officially announces the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. Completion must be confirmed through an official CMA announcement or reported by at least two major news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not announce the completion of such an investigation by this date, or if the investigation is still ongoing, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4494897427831781, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.65, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "7dcdbd37-be1b-467a-a328-53f38acb8213", "title": "Will the CMA not announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK does not officially announce the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. Completion must not be confirmed through an official CMA announcement or reported by at least two major news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does announce the completion of such an investigation by this date, or if the investigation is still ongoing, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "ec06f141-c8c1-47b1-98ee-34f9f42e791c", "title": "Is it expected that the CMA will declare the conclusion of a significant inquiry into pharmaceutical pricing before July 2024?", "body": "This inquiry will be considered resolved as YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) makes an official statement regarding the conclusion of its investigation into the pricing practices of at least five major pharmaceutical companies. The conclusion must be verified through an official announcement from the CMA or reported by at least two prominent news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA fails to announce the conclusion of such an inquiry by this deadline, or if the investigation remains active, the inquiry will be resolved as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "714610b8-14ba-4e3d-9175-3f731cb1d31d", "title": "Will the CMA fail to declare the conclusion of a significant investigation into pharmaceutical pricing by July 2024?", "body": "This inquiry will be answered with YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) does not make an official statement regarding the conclusion of its investigation into the pricing practices of at least five major pharmaceutical companies. The conclusion must not be validated through an official announcement from the CMA or reported by at least two prominent news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA makes an announcement about the conclusion of this investigation by that date, or if the investigation remains active, the response will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3121185996084903, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.3, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "bc2c6a10-1c96-4f66-ba52-0657b5ac0f11", "title": "Will the CMA not fail to declare the conclusion of a significant investigation into pharmaceutical pricing by July 2024?", "body": "This inquiry will be answered with YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) makes an official statement regarding the conclusion of its investigation into the pricing practices of at least five major pharmaceutical companies. The conclusion must be validated through an official announcement from the CMA or reported by at least two prominent news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not make an announcement about the conclusion of this investigation by that date, or if the investigation remains active, the response will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "10f7b7e9-d7fb-483b-98d5-9d19c11cdf83", "title": "Will the CMA not announce the outcome of a major probe into drug pricing before July 2024?", "body": "This question will receive a YES answer if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) has not issued an official statement regarding the outcome of its probe into the pricing strategies of at least five leading pharmaceutical firms. The outcome must not be confirmed through an official declaration from the CMA or reported by at least two major news outlets (like Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does announce the outcome of this probe by that date, or if the investigation is still ongoing, the answer will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3, "elicitation_metadata": null}}}]}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "d9f59fe6-876e-42b5-9114-859deb797359", "title": "Is it expected that the CMA will declare the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be deemed affirmative if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) formally declares the conclusion of its probe into pharmaceutical pricing practices involving a minimum of five leading companies. The conclusion must be verified through an official announcement from the CMA or reported by at least two prominent news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not make such an announcement by this deadline, or if the inquiry remains active, the inquiry will be considered negative.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.5690816520781352, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.6377578334439237, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.65, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "4d792dbf-6efe-4172-bdc6-8afad146c1d0", "title": "Is it expected that the CMA will not declare the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be deemed affirmative if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) does not formally declare the conclusion of its probe into pharmaceutical pricing practices involving a minimum of five leading companies. The conclusion must not be verified through an official announcement from the CMA or reported by at least two prominent news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA makes such an announcement by this deadline, or if the inquiry is no longer active, the inquiry will be considered negative.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "c5d8a889-2230-4cf2-9784-dee96e88f35b", "title": "Will the CMA announce the end of a major investigation into drug pricing before July 2024?", "body": "This investigation will be classified as positive if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) officially announces the completion of its investigation into pricing practices of at least five major pharmaceutical companies. The conclusion must be confirmed through an official statement from the CMA or reported by a minimum of two major news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA fails to make such an announcement by this date, or if the investigation is still ongoing, it will be regarded as negative.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "dd5bb7f2-6153-49af-b8ab-9dfcc0ebee22", "title": "Is it expected that the CMA will not declare the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be deemed negative if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) does not formally declare the conclusion of its probe into pharmaceutical pricing practices involving a minimum of five leading companies. The conclusion must not be verified through an official announcement from the CMA or reported by at least two prominent news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA makes such an announcement by this deadline, or if the inquiry is concluded, the inquiry will be considered affirmative.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.5727744866837517, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "db4f6655-033b-468f-b12a-5d24ce664d6e", "title": "Is it expected that the CMA will declare the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be deemed affirmative if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) formally declares the conclusion of its probe into pharmaceutical pricing practices involving a minimum of five leading companies. The conclusion must be verified through an official announcement from the CMA or reported by at least two prominent news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not make such an announcement by this deadline, or if the inquiry is not concluded, the inquiry will be considered negative.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "4c357fdd-a3e8-462d-9471-dd2e1a33c556", "title": "Is it anticipated that the CMA will refrain from announcing the outcome of a major investigation into drug pricing before July 2024?", "body": "This investigation will be classified as negative if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) has not officially announced the outcome of its investigation into drug pricing practices involving at least five major companies. The outcome must not be confirmed through an official statement from the CMA or reported by a minimum of two major news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA issues such a statement by this date, or if the investigation is concluded, the investigation will be regarded as positive.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.75, "elicitation_metadata": null}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "4716fddb-3f40-4c3c-9aff-e00bd4f9333e", "title": "Will the CMA announce the conclusion of a major investigation into drug pricing by July 2024?", "body": "This investigation will be considered positive if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) officially announces the end of its investigation into the pricing practices of at least five major companies in the pharmaceutical sector. The conclusion must be confirmed through a formal statement from the CMA or reported by a minimum of two major news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA fails to issue such an announcement by this date, or if the investigation is still ongoing, the inquiry will be regarded as negative.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.6034779357384628, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "6b1f8045-51f1-4b10-8bc0-64ff83f069a4", "title": "Will the CMA not announce the conclusion of a major investigation into drug pricing by July 2024?", "body": "This investigation will be considered negative if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) does not officially announce the end of its investigation into the pricing practices of at least five major companies in the pharmaceutical sector. The conclusion must not be confirmed through a formal statement from the CMA or reported by a minimum of two major news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA issues such an announcement by this date, or if the investigation is not still ongoing, the inquiry will be regarded as positive.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "9fcb4c98-3e08-4375-8291-d23717a079a5", "title": "Will the CMA reveal the results of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be deemed successful if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) officially declares the conclusion of its investigation into the pricing strategies of at least five leading companies in the drug industry. The conclusion must be validated through a formal announcement from the CMA or reported by at least two major news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not make such an announcement by this date, or if the investigation remains active, the inquiry will be viewed as unsuccessful.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}]}}}]}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "4a2a3e96-9a5d-42f6-8503-f625b1eb2b04", "title": "Will the CMA not announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK does not officially announce the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. Completion must not be confirmed through an official CMA announcement or reported by at least two major news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA announces the completion of such an investigation by this date, or if the investigation is still ongoing, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4574088589531415, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.3367213532126123, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.33631152003358045, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "737e62e6-fa28-4b2c-a6c7-73fb5e84a5d2", "title": "Will the CMA announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK officially announces the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. Completion must be confirmed through an official CMA announcement or reported by at least two major news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not announce the completion of such an investigation by this date, or if the investigation is still ongoing, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "5a85bcdd-fcef-423d-b7e2-06e0dca0cd6a", "title": "Will the CMA refrain from declaring the conclusion of a significant pharmaceutical pricing inquiry by July 2024?", "body": "This inquiry will be considered TRUE if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) has not made an official statement regarding the conclusion of its investigation into the pricing practices of at least five major pharmaceutical firms. The conclusion must not be validated through an official announcement from the CMA or reported by a minimum of two prominent news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). Should the CMA declare the investigation's conclusion by this date, or if the investigation continues, the inquiry will be deemed FALSE.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3, "elicitation_metadata": null}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "9c871d49-d139-4400-800d-004537268dd0", "title": "Will the CMA announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK officially announces the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. Completion must be confirmed through an official CMA announcement or reported by at least two major news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not announce the completion of such an investigation by this date, or if the investigation is still ongoing, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.6377578334439237, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.65, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "2f8e4868-955b-472c-9272-c787569fa424", "title": "Will the CMA not announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK does not officially announce the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. Completion must not be confirmed through an official CMA announcement or reported by at least two major news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does announce the completion of such an investigation by this date, or if the investigation is still ongoing, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "b1e1e0b7-fc82-4b6e-9975-8154b062b982", "title": "Is it expected that the CMA will declare the end of a significant investigation into pharmaceutical pricing by July 2024?", "body": "This inquiry will be considered YES if, by July 31, 2024, the UK\u2019s Competition and Markets Authority (CMA) publicly confirms the conclusion of its inquiry into the pricing practices of at least five major pharmaceutical companies. The conclusion must be validated through an official announcement from the CMA or reported by a minimum of two prominent news organizations (like Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA fails to announce the completion of the investigation by this date, or if the investigation remains active, the inquiry will be deemed NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "b0d8e00c-810d-4e56-bd30-d25be09f132c", "title": "Will the CMA refrain from declaring the conclusion of a significant investigation into pharmaceutical pricing before July 2024?", "body": "This inquiry will be answered with YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK has not made an official statement regarding the conclusion of its investigation into pricing practices in the pharmaceutical sector involving a minimum of five major firms. The conclusion must not be verified through an official announcement from the CMA or reported by at least two prominent news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does announce the conclusion of this investigation by the specified date, or if the investigation remains active, the response will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3244997998398398, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.35, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "ea6308a0-df98-43d2-b7ac-cffd039a9a57", "title": "Will the CMA declare the conclusion of a significant investigation into pharmaceutical pricing before July 2024?", "body": "This inquiry will be answered with YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK has made an official statement regarding the conclusion of its investigation into pricing practices in the pharmaceutical sector involving a minimum of five major firms. The conclusion must be verified through an official announcement from the CMA or reported by at least two prominent news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not announce the conclusion of this investigation by the specified date, or if the investigation remains active, the response will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "48a4c224-951d-4f38-9f09-d970aebdf411", "title": "Will the CMA hold off on announcing the results of a major inquiry into drug pricing until after July 2024?", "body": "This question will receive a YES answer if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK has not issued any formal communication regarding the outcome of its inquiry into pricing strategies in the pharmaceutical industry involving at least five significant companies. The outcome must not be confirmed by an official statement from the CMA or reported by at least two major news outlets (like Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does reveal the results of this inquiry by the given date, or if the investigation is still ongoing, the answer will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3, "elicitation_metadata": null}}}]}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "8f893802-c3fc-4962-a4ea-736e725069dd", "title": "Will the CMA announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK officially announces the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. Completion must be confirmed through an official CMA announcement or reported by at least two major news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not announce the completion of such an investigation by this date, or if the investigation is still ongoing, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.5421561736777654, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.6628685678732142, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.65, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "79a00a8d-0d1e-4b66-aeb4-24d9d47edc31", "title": "Will the CMA not announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK does not officially announce the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. Completion must not be confirmed through an official CMA announcement or reported by at least two major news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does announce the completion of such an investigation by this date, or if the investigation is still ongoing, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "07f614d2-de0a-4354-aa5a-96a21c5433ca", "title": "Will the CMA declare the conclusion of a significant investigation into pharmaceutical pricing before July 2024?", "body": "This inquiry will be answered with YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK makes an official statement regarding the conclusion of its investigation into the pricing practices of at least five major pharmaceutical firms. The conclusion must be validated through an official announcement from the CMA or reported by a minimum of two prominent news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA fails to announce the conclusion of such an investigation by this deadline, or if the investigation remains active, the answer will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "770b77c8-a646-473c-be79-50a4b959acef", "title": "Will the CMA not announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK does not officially announce the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. Completion must not be confirmed through an official CMA announcement or reported by at least two major news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA announces the completion of such an investigation by this date, or if the investigation is still ongoing, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3244997998398398, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.35, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "52b65650-4fb8-461d-b427-bf2a4e4935c3", "title": "Will the CMA announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK officially announces the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. Completion must be confirmed through an official CMA announcement or reported by at least two major news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not announce the completion of such an investigation by this date, or if the investigation is still ongoing, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "ef680522-795d-4c12-8f53-19d65d089445", "title": "Will the CMA fail to declare the conclusion of a significant pharmaceutical pricing inquiry by July 2024?", "body": "This question will be answered with a YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) does not make an official declaration regarding the conclusion of its investigation into the pricing practices of at least five major pharmaceutical companies. The conclusion must not be confirmed via an official announcement from the CMA or reported by at least two major news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). Conversely, if the CMA does announce the conclusion of this investigation by the specified date, or if the investigation remains active, the answer will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3, "elicitation_metadata": null}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "2b932ac0-b163-4fff-858e-2691115e0a35", "title": "Is it expected that the CMA will declare the conclusion of a significant inquiry into pharmaceutical pricing before July 2024?", "body": "This inquiry will be considered resolved as YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) officially declares that it has completed its investigation into pricing practices of at least five major pharmaceutical companies. The conclusion must be verified through an official announcement from the CMA or reported by a minimum of two major news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA fails to announce the conclusion of such an inquiry by this date, or if the inquiry remains active, the question will be resolved as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.40936664015471363, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.65, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "3f910115-896f-4543-a8fe-dc15b49d7bb8", "title": "Is it expected that the CMA will not declare the conclusion of a significant inquiry into pharmaceutical pricing before July 2024?", "body": "This inquiry will be considered resolved as YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) does not officially declare that it has completed its investigation into pricing practices of at least five major pharmaceutical companies. The conclusion must not be verified through an official announcement from the CMA or reported by a minimum of two major news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does announce the conclusion of such an inquiry by this date, or if the inquiry is not active, the question will be resolved as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.7, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "3f867dcf-5a1e-4a50-801d-0050679a93e6", "title": "Will the CMA announce the end of a major investigation into drug pricing prior to July 2024?", "body": "This investigation will be deemed resolved as YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) officially states that it has finished its probe into the pricing strategies of at least five leading pharmaceutical firms. The conclusion must be confirmed through an official statement from the CMA or reported by at least two prominent news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not declare the conclusion of such an investigation by this date, or if the investigation is still ongoing, the question will be resolved as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.35, "elicitation_metadata": null}}}]}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "3bb96e35-f8f7-43f6-9288-4e28e10a733a", "title": "Will the CMA refrain from declaring the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be answered with YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) does not officially declare that it has completed its investigation into the pricing practices of at least five major pharmaceutical companies. The conclusion must not be verified through an official announcement from the CMA or reported by at least two major news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does announce the completion of this investigation by the specified date, or if the investigation remains in progress, the answer will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.5204700161239844, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.576767997638424, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "277f1517-a276-48a6-91b8-9149b0584dcd", "title": "Will the CMA not refrain from declaring the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be answered with YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) officially declares that it has completed its investigation into the pricing practices of at least five major pharmaceutical companies. The conclusion must be verified through an official announcement from the CMA or reported by at least two major news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not announce the completion of this investigation by the specified date, or if the investigation is completed, the answer will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "77a52bbd-8011-4abc-af44-88ba10c42689", "title": "Will the CMA avoid announcing the completion of a major investigation into drug pricing by July 2024?", "body": "This inquiry will receive a YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) has not formally stated that it has finished its investigation into the pricing strategies of at least five leading pharmaceutical firms. The conclusion must not be confirmed through an official statement from the CMA or reported by at least two major news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does declare the conclusion of this investigation by the given date, or if the investigation is still ongoing, the answer will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "81e11e29-eba3-46f4-ae68-b17655700c0a", "title": "Will the CMA not refrain from declaring the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be answered with YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) officially declares that it has completed its investigation into the pricing practices of at least five major pharmaceutical companies. The conclusion must be verified through an official announcement from the CMA or reported by at least two major news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not announce the completion of this investigation by the specified date, or if the investigation remains in progress, the answer will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.39564392373896007, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "254f8dcb-cacd-4e28-8b47-d6c56e11f2a4", "title": "Will the CMA refrain from declaring the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be answered with YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) does not officially declare that it has completed its investigation into the pricing practices of at least five major pharmaceutical companies. The conclusion must not be verified through an official announcement from the CMA or reported by at least two major news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does announce the completion of this investigation by the specified date, or if the investigation is completed, the answer will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "4e99360d-9db3-4a9e-bcfe-f6785cedd856", "title": "Will the CMA choose to announce the outcome of a major investigation into drug pricing before July 2024?", "body": "This inquiry will receive a YES response if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) officially states that it has finalized its examination of the pricing strategies of at least five leading pharmaceutical firms. The conclusion must be confirmed through an official statement from the CMA or reported by no fewer than two prominent news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA fails to declare the completion of this investigation by the given deadline, or if the investigation is still ongoing, the answer will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3, "elicitation_metadata": null}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "9f9bf21a-49f6-4ff0-bf49-5afcc0830a44", "title": "Will the CMA avoid announcing the outcome of a major investigation into drug pricing before July 2024?", "body": "This inquiry will be considered as YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) has not publicly stated that it has finished its examination of the pricing strategies of at least five leading pharmaceutical firms. The conclusion should not be confirmed through an official declaration from the CMA or reported by a minimum of two prominent news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does declare the completion of this inquiry by the given date, or if the inquiry is still ongoing, the response will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4494897427831781, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "5a6fd4dd-c93f-4de2-bf51-7edd46115f5d", "title": "Will the CMA announce the outcome of a major investigation into drug pricing before July 2024?", "body": "This inquiry will be considered as YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) has publicly stated that it has finished its examination of the pricing strategies of at least five leading pharmaceutical firms. The conclusion should be confirmed through an official declaration from the CMA or reported by a minimum of two prominent news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not declare the completion of this inquiry by the given date, or if the inquiry is still ongoing, the response will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "9af21cf2-c8ec-4433-ba5b-fbdd289cfc78", "title": "Will the CMA refrain from revealing the results of a significant investigation into pharmaceutical pricing prior to July 2024?", "body": "This question will be answered with YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) has not made a public announcement that it has concluded its review of the pricing practices of at least five major drug companies. The conclusion must not be validated through an official statement from the CMA or covered by at least two major news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does announce the conclusion of this investigation by the specified date, or if the investigation remains in progress, the answer will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}]}}}]}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "afddd9e7-9f81-4620-9851-d6039ddb9682", "title": "Will the CMA declare the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be deemed as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK formally declares that its investigation into the pricing practices of at least five major pharmaceutical companies has concluded. The conclusion must be verified through an official announcement from the CMA or reported by a minimum of two prominent news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA fails to announce the conclusion of this investigation by the specified date, or if the investigation remains in progress, the inquiry will be considered as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.49379774172419677, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4656085782160018, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4494897427831781, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "a4244764-6bc9-4853-bb96-938d528ca9b8", "title": "Will the CMA not declare the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be deemed as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK does not formally declare that its investigation into the pricing practices of at least five major pharmaceutical companies has concluded. The conclusion must not be verified through an official announcement from the CMA or reported by a minimum of two prominent news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA announces the conclusion of this investigation by the specified date, or if the investigation is concluded, the inquiry will be considered as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "ebbcecd6-f31f-43e7-b1e1-76ff1cfccdfc", "title": "Will the CMA announce the end of a major investigation into drug pricing by July 2024?", "body": "This inquiry will be classified as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK officially states that its examination of the pricing strategies of at least five major pharmaceutical firms has finished. The conclusion must be confirmed through a formal statement from the CMA or covered by at least two leading news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not declare the end of this investigation by the given date, or if the inquiry is still ongoing, the inquiry will be marked as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "deae559c-9d9a-4360-b477-9a742150d683", "title": "Will the CMA not declare the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be deemed as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK does not formally declare that its investigation into the pricing practices of at least five major pharmaceutical companies has concluded. The conclusion must not be verified through an official announcement from the CMA or reported by a minimum of two prominent news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA announces the conclusion of this investigation by the specified date, or if the investigation is concluded, the inquiry will be considered as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.48573770432398344, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.3, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "6d8fd89c-2de7-4436-b9c1-9916e07e1be4", "title": "Will the CMA declare the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be deemed as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK does formally declare that its investigation into the pricing practices of at least five major pharmaceutical companies has concluded. The conclusion must be verified through an official announcement from the CMA or reported by a minimum of two prominent news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not announce the conclusion of this investigation by the specified date, or if the investigation is not concluded, the inquiry will be considered as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "4911efd2-d38a-479b-ada3-b6be8c746ad7", "title": "Will the CMA refrain from announcing the end of a major investigation into drug pricing before July 2024?", "body": "This inquiry will be classified as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK has not officially stated that its probe into the pricing strategies of at least five leading pharmaceutical firms has finished. The conclusion must not be confirmed through an official declaration from the CMA or reported by at least two major news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA declares the end of this investigation by the given date, or if the investigation is resolved, the inquiry will be deemed as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "6478a29f-1495-48b4-aba1-25f6605db2fc", "title": "Will the CMA announce the end of a major investigation into drug pricing by July 2024?", "body": "This inquiry will be classified as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK officially states that its examination of the pricing strategies of at least five leading pharmaceutical firms has been completed. The conclusion must be confirmed through a formal statement from the CMA or reported by at least two reputable news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not declare the end of this investigation by the designated date, or if the investigation is still ongoing, the inquiry will be categorized as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4494897427831781, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "a7d0cafb-c634-497a-a0e1-7b0db67c640a", "title": "Will the CMA not announce the end of a major investigation into drug pricing by July 2024?", "body": "This inquiry will be classified as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK does not officially state that its examination of the pricing strategies of at least five leading pharmaceutical firms has been completed. The conclusion must not be confirmed through a formal statement from the CMA or reported by at least two reputable news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does declare the end of this investigation by the designated date, or if the investigation is still ongoing, the inquiry will be categorized as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "de0078d7-8c5b-4348-853e-7e9c51b51a0a", "title": "Will the CMA declare the conclusion of a significant probe into pharmaceutical pricing before July 2024?", "body": "This question will be answered with YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK formally announces that its investigation into the pricing practices of at least five major drug companies has been finalized. This conclusion must be verified through an official announcement from the CMA or reported by at least two credible news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not officially announce the conclusion of this investigation by the specified date, or if the investigation remains active, the answer will be classified as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}]}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "cc9a683b-0b83-442a-a3c0-41ecd4e8e3dd", "title": "Will the CMA not declare the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be deemed as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK does not formally declare that its investigation into the pricing practices of at least five major pharmaceutical companies has concluded. The conclusion must not be verified through an official announcement from the CMA or reported by a minimum of two prominent news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA announces the conclusion of this investigation by the specified date, or if the investigation is concluded, the inquiry will be considered as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.44746791170352007, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.39564392373896007, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "b76457bc-b213-4873-a94e-ec188ebfa982", "title": "Will the CMA declare the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be deemed as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK does formally declare that its investigation into the pricing practices of at least five major pharmaceutical companies has concluded. The conclusion must be verified through an official announcement from the CMA or reported by a minimum of two prominent news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not announce the conclusion of this investigation by the specified date, or if the investigation is not concluded, the inquiry will be considered as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "b066c288-c1a2-499f-b40d-71a633e05dc0", "title": "Is it possible that the CMA will not announce the end of a major investigation into drug pricing by July 2024?", "body": "This inquiry will be marked as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK has not officially stated that its probe into the pricing strategies of at least five leading pharmaceutical companies has been completed. The conclusion must not be confirmed by an official statement from the CMA or reported by at least two major news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). Should the CMA declare the end of this investigation by the specified date, or if the investigation reaches a conclusion, the inquiry will be classified as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3, "elicitation_metadata": null}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "237a2d26-0d88-4fd0-bd24-c5ad39f60441", "title": "Will the CMA declare the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be deemed as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK formally declares that its investigation into the pricing practices of at least five major pharmaceutical companies has concluded. The conclusion must be verified through an official announcement from the CMA or reported by a minimum of two prominent news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not announce the conclusion of this investigation by the specified date, or if the investigation is not concluded, the inquiry will be considered as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4769477628186271, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "c47e72aa-738e-426a-a68e-a6190f12581d", "title": "Will the CMA not declare the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be deemed as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK does not formally declare that its investigation into the pricing practices of at least five major pharmaceutical companies has concluded. The conclusion must not be verified through an official announcement from the CMA or reported by a minimum of two prominent news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does announce the conclusion of this investigation by the specified date, or if the investigation is concluded, the inquiry will be considered as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "23b16df1-1413-428a-ba85-9aa1a3557bef", "title": "Will the CMA announce the end of a major investigation into drug pricing by July 2024?", "body": "This inquiry will be marked as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK officially states that its probe into the pricing strategies of at least five leading pharmaceutical firms has been completed. The conclusion must be confirmed through a formal statement from the CMA or reported by at least two well-known news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA fails to declare the end of this investigation by the deadline, or if the investigation remains open, the inquiry will be classified as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "ee38eaa5-5ec6-4365-81ae-8af7aa05d77e", "title": "Is it possible that the CMA will fail to announce the end of a major investigation into drug pricing before July 2024?", "body": "This inquiry will be regarded as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK has not officially stated that its probe into the pricing strategies of at least five leading pharmaceutical firms has finished. The conclusion must not be confirmed through a formal statement from the CMA or reported by at least two major news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA declares the end of this investigation by the given date, or if the investigation is wrapped up, the inquiry will be viewed as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.43631624107272954, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.35, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "ad44d915-c2e9-496b-89fb-c90f1f623712", "title": "Is it impossible that the CMA will fail to announce the end of a major investigation into drug pricing before July 2024?", "body": "This inquiry will be regarded as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK has officially stated that its probe into the pricing strategies of at least five leading pharmaceutical firms has finished. The conclusion must be confirmed through a formal statement from the CMA or reported by at least two major news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not declare the end of this investigation by the given date, or if the investigation is not wrapped up, the inquiry will be viewed as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "37508944-89e2-43c8-83e0-10dd0691901b", "title": "Could the CMA potentially not declare the conclusion of a significant investigation into pharmaceutical pricing prior to July 2024?", "body": "This inquiry will be considered YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK has not made an official announcement that its investigation into the pricing practices of at least five major drug companies has been completed. The conclusion must not be validated through a formal announcement from the CMA or reported by at least two prominent news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA announces the conclusion of this investigation by the specified date, or if the investigation is concluded, the inquiry will be interpreted as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}]}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "ceb4e0f7-255c-4f8c-b6fa-34ab92c37a7c", "title": "Will the CMA announce the end of a major investigation into drug pricing before July 2024?", "body": "This inquiry will be regarded as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK officially states that its examination of the pricing strategies of at least five leading pharmaceutical firms has been completed. The conclusion must be confirmed through an official statement from the CMA or reported by at least two reputable news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not declare the end of this investigation by the given date, or if the investigation is still ongoing, the inquiry will be deemed as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4784677440290695, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4102545628569667, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.35, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "3793d116-062e-4b8b-b482-967f4b55c6ae", "title": "Will the CMA not announce the end of a major investigation into drug pricing before July 2024?", "body": "This inquiry will be regarded as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK does not officially state that its examination of the pricing strategies of at least five leading pharmaceutical firms has been completed. The conclusion must not be confirmed through an official statement from the CMA or reported by at least two reputable news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does declare the end of this investigation by the given date, or if the investigation is still ongoing, the inquiry will be deemed as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "0802985b-ecb9-47c1-8485-8a4002a7fa6d", "title": "Will the CMA disclose the conclusion of a significant probe into medication pricing prior to July 2024?", "body": "This investigation will be considered a YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK officially announces that its review of the pricing practices of at least five major pharmaceutical companies has been finalized. The conclusion must be validated through an official announcement from the CMA or reported by a minimum of two credible news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not announce the conclusion of this probe by the specified date, or if the inquiry remains active, the investigation will be classified as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.35, "elicitation_metadata": null}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "166236dd-5db6-4cf8-95bf-d695b8501620", "title": "Will the CMA not announce the end of a major investigation into drug pricing before July 2024?", "body": "This inquiry will be regarded as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK does not officially state that its examination of the pricing strategies of at least five leading pharmaceutical firms has been completed. The conclusion must not be confirmed through an official statement from the CMA or reported by at least two reputable news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does declare the end of this investigation by the given date, or if the investigation is still ongoing, the inquiry will be deemed as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.39564392373896007, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "c334911f-5a96-47fb-8045-a280ca7691e3", "title": "Will the CMA announce the end of a major investigation into drug pricing before July 2024?", "body": "This inquiry will be regarded as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK officially states that its examination of the pricing strategies of at least five leading pharmaceutical firms has been completed. The conclusion must be confirmed through an official statement from the CMA or reported by at least two reputable news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not declare the end of this investigation by the given date, or if the investigation is still ongoing, the inquiry will be deemed as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "bb55e3ec-f87d-4092-bf12-ad64a006b68d", "title": "Will the CMA refrain from declaring the conclusion of a significant probe into pharmaceutical pricing prior to July 2024?", "body": "This inquiry will be considered a YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK has not made an official announcement that its investigation into the pricing practices of at least five major drug companies has been finalized. The conclusion must not be verified through a formal statement from the CMA or reported by at least two credible news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). Conversely, if the CMA does announce the conclusion of this investigation by the specified date, or if the investigation remains in progress, the inquiry will be classified as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3, "elicitation_metadata": null}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "115757c0-3a99-46f5-85af-5f8ca5136005", "title": "Will the CMA declare the conclusion of a significant probe into pharmaceutical pricing prior to July 2024?", "body": "This investigation will be considered a YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK officially announces that its review of the pricing practices of at least five major drug companies has been finalized. The conclusion must be validated through an official announcement from the CMA or reported by a minimum of two credible news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA fails to announce the conclusion of this investigation by the specified date, or if the inquiry remains active, the response will be classified as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4494897427831781, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "79146782-9732-485e-9eba-f9da2a5df496", "title": "Will the CMA not declare the conclusion of a significant probe into pharmaceutical pricing prior to July 2024?", "body": "This investigation will be considered a YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK does not officially announce that its review of the pricing practices of at least five major drug companies has been finalized. The conclusion must not be validated through an official announcement from the CMA or reported by fewer than two credible news organizations (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does announce the conclusion of this investigation by the specified date, or if the inquiry is no longer active, the response will be classified as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "7658b672-34e3-4b99-b7a8-19dc51b84ff2", "title": "Will the CMA announce the end of a major investigation into drug pricing before July 2024?", "body": "This inquiry will be deemed a YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK makes an official declaration that its examination of the pricing strategies of at least five significant pharmaceutical companies has been completed. The conclusion must be confirmed through an official statement from the CMA or reported by at least two reputable news outlets (such as Reuters, Associated Press, Wall Street Journal, or New York Times). If the CMA does not declare the conclusion of this investigation by the given date, or if the investigation is still ongoing, the answer will be categorized as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}]}}}]}}}]}}}]}}, "not_P": {"question": {"id": "e7613c3a-6ca2-4401-b869-e7454ae91b7b", "title": "Will the CMA not announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK does not officially announce the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. If the CMA announces the completion of such an investigation by this date, the question resolves as NO.", "resolution_date": "2024-07-31T23:59:59Z", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30T23:59:59Z", "url": null, "metadata": {}, "resolution": true}, "forecast": {"prob": 0.5036661857230305, "metadata": [{"name": "P", "elicited_prob": 0.46709677789063947, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.5160024127807111, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.3872566226962701, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "c73967a2-2e14-4553-bebe-930f7c09f42e", "title": "Will the CMA announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK officially announces the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. If the CMA does not announce the completion of such an investigation by this date, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "1cc0b8c7-9d66-40c5-b3c6-a850249533a0", "title": "Is it possible that the CMA will refrain from declaring the conclusion of a significant inquiry into pharmaceutical pricing before July 2024?", "body": "This question will be answered with YES if, by July 31, 2024, the UK\u2019s Competition and Markets Authority (CMA) has not made an official statement regarding the conclusion of its investigation into the pricing practices of at least five major pharmaceutical firms. Conversely, if the CMA does announce the conclusion of this investigation by that date, the answer will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "5fab7241-14f6-4796-96ab-35ee4063ba0e", "title": "Will the CMA announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK officially announces the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. If the CMA does not announce the completion of such an investigation by this date, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.576767997638424, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.65, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "5bcd2233-47f0-4c50-9161-989b98a84b37", "title": "Will the CMA not announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK does not officially announce the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. If the CMA announces the completion of such an investigation by this date, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "edb653e8-fab3-4064-9024-be5ea39ea240", "title": "Is it expected that the CMA will declare the conclusion of a significant inquiry into pharmaceutical pricing before July 2024?", "body": "This inquiry will be considered resolved as YES if, by the end of July 2024, the UK's Competition and Markets Authority (CMA) publicly states that it has finished its investigation into the pricing practices of at least five major pharmaceutical firms. Conversely, if the CMA fails to make such an announcement by this deadline, the inquiry will resolve as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "390fa525-825e-4610-ba69-6c40584b660f", "title": "Will the CMA refrain from declaring the conclusion of a significant pharmaceutical pricing inquiry before July 2024?", "body": "This inquiry will be answered with YES if, by July 31, 2024, the UK\u2019s Competition and Markets Authority (CMA) does not make an official statement regarding the conclusion of its investigation into the pricing practices of at least five major pharmaceutical companies. Conversely, if the CMA does announce the conclusion of this investigation by the specified date, the answer will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.6253342843561662, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.6, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "f7676159-8134-4853-936b-49b7c7966d72", "title": "Will the CMA not refrain from declaring the conclusion of a significant pharmaceutical pricing inquiry before July 2024?", "body": "This inquiry will be answered with YES if, by July 31, 2024, the UK\u2019s Competition and Markets Authority (CMA) makes an official statement regarding the conclusion of its investigation into the pricing practices of at least five major pharmaceutical companies. Conversely, if the CMA does not announce the conclusion of this investigation by the specified date, the answer will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "be1662aa-4d3b-4bc7-9d5c-9a804e74b316", "title": "Will the CMA hold off on announcing the results of a major pharmaceutical pricing investigation until after July 2024?", "body": "This inquiry will be answered with YES if, by July 31, 2024, the UK\u2019s Competition and Markets Authority (CMA) has not released an official statement about the outcome of its probe into the pricing strategies of at least five significant pharmaceutical firms. On the other hand, if the CMA does reveal the results of this investigation by that date, the answer will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}]}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "308d121b-d750-4a2d-bd74-7b8ac3af9178", "title": "Will the CMA announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK officially announces the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. If the CMA does not announce the completion of such an investigation by this date, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.5562010484269986, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.6377578334439237, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.65, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "0fdd9223-bf41-4457-affd-555fb937e565", "title": "Will the CMA not announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK does not officially announce the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. If the CMA does announce the completion of such an investigation by this date, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "f6eb4873-6928-4f41-8d18-c6928c23ad8f", "title": "Is it expected that the CMA will declare the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This question will be considered as YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) makes an official statement regarding the conclusion of its investigation into pricing practices of at least five major pharmaceutical companies. Conversely, if the CMA fails to announce the conclusion of this investigation by that date, the question will resolve as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "fe8a3473-f488-4841-a8f1-8028fe7fd4d4", "title": "Will the CMA not announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK does not officially announce the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. If the CMA announces the completion of such an investigation by this date, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.541783042161398, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "757ff540-27b3-4e78-9961-1e1b3ff904d7", "title": "Will the CMA announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK officially announces the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. If the CMA does not announce the completion of such an investigation by this date, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "70c85701-f780-4660-9a20-d8e83246893d", "title": "Will the CMA refrain from declaring the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This question will be answered with YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) has not made an official statement regarding the conclusion of its investigation into the pricing practices of at least five major pharmaceutical companies. Conversely, if the CMA does announce the conclusion of this investigation by the specified date, the answer will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.7, "elicitation_metadata": null}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "38774e6c-bd74-49b5-932b-ec5be7f42268", "title": "Is it expected that the CMA will declare the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be considered YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) makes an official statement regarding the conclusion of its investigation into pricing practices in the pharmaceutical sector that involves at least five major firms. If the CMA fails to make such an announcement by this deadline, the inquiry will be marked as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.5627806530671691, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.65, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "6f29d748-3561-4a76-ac5c-aecc9f8b971e", "title": "Is it expected that the CMA will not declare the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be considered YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) does not make an official statement regarding the conclusion of its investigation into pricing practices in the pharmaceutical sector that involves at least five major firms. If the CMA makes such an announcement by this deadline, the inquiry will be marked as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.7, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "3c0ddceb-94e3-481d-a12a-b9e5c32a9450", "title": "Will the CMA announce the outcome of a major investigation into drug pricing before July 2024?", "body": "This inquiry will be marked YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) issues an official statement about the completion of its investigation into pricing practices within the pharmaceutical industry, which includes at least five significant companies. If the CMA does not provide such an announcement by this date, the inquiry will be recorded as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}]}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "e5836156-4063-4a6a-b6ad-d67b1137d97f", "title": "Is it possible that the CMA will not declare the conclusion of a significant inquiry into pharmaceutical pricing before July 2024?", "body": "This inquiry will be considered TRUE if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) fails to make an official statement regarding the conclusion of its investigation into the pricing practices of at least five major pharmaceutical companies. Conversely, if the CMA does declare the completion of this investigation by the specified date, the inquiry will be deemed FALSE.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4544408665540402, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.3834695411018051, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "f1d335a5-ae37-4d90-ae1e-adbcdc45a026", "title": "Is it possible that the CMA will declare the conclusion of a significant inquiry into pharmaceutical pricing before July 2024?", "body": "This inquiry will be considered TRUE if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) makes an official statement regarding the conclusion of its investigation into the pricing practices of at least five major pharmaceutical companies. Conversely, if the CMA does not declare the completion of this investigation by the specified date, the inquiry will be deemed FALSE.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.45, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "e2a15df4-de02-4257-b5b0-8aaa7ba2c692", "title": "Could the CMA refrain from announcing the outcome of a major investigation into drug pricing prior to July 2024?", "body": "This inquiry will be regarded as TRUE if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) has not issued an official announcement concerning the results of its investigation into the pricing strategies of at least five significant pharmaceutical firms. On the other hand, if the CMA does announce the conclusion of this investigation by the given date, the inquiry will be considered FALSE.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3, "elicitation_metadata": null}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "d7427855-e379-421c-9d82-ab2634fb849c", "title": "Is it possible that the CMA will declare the conclusion of a significant inquiry into pharmaceutical pricing before July 2024?", "body": "This inquiry will be considered TRUE if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) makes an official statement regarding the conclusion of its investigation into the pricing practices of at least five major pharmaceutical companies. Conversely, if the CMA does not declare the completion of this investigation by the specified date, the inquiry will be deemed FALSE.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4627344754546939, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "c83fbe9d-95ad-4c52-94da-fac5934aad8f", "title": "Is it not possible that the CMA will declare the conclusion of a significant inquiry into pharmaceutical pricing before July 2024?", "body": "This inquiry will be considered TRUE if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) does not make an official statement regarding the conclusion of its investigation into the pricing practices of at least five major pharmaceutical companies. Conversely, if the CMA declares the completion of this investigation by the specified date, the inquiry will be deemed FALSE.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.35, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "42e50949-c0e0-41c6-8ed1-d7874e981e34", "title": "Could the CMA announce the end of a major investigation into drug pricing prior to July 2024?", "body": "This investigation will be regarded as TRUE if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) issues an official announcement about the conclusion of its probe into the pricing strategies of at least five leading pharmaceutical firms. On the other hand, if the CMA fails to announce the completion of this probe by the given date, the investigation will be considered FALSE.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "8b1e55db-9e63-4d41-a6fd-9758c0ea1a64", "title": "Could the CMA potentially not announce the outcome of a major investigation into drug pricing prior to July 2024?", "body": "This inquiry will be regarded as TRUE if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) does not issue an official announcement concerning the completion of its probe into the pricing strategies of a minimum of five leading pharmaceutical firms. On the other hand, if the CMA does announce the conclusion of this investigation by the given date, the inquiry will be considered FALSE.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4494897427831781, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "7d27dc65-4ee4-420e-b696-6ad65d36ba46", "title": "Could the CMA potentially announce the outcome of a major investigation into drug pricing prior to July 2024?", "body": "This inquiry will be regarded as TRUE if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) does issue an official announcement concerning the completion of its probe into the pricing strategies of a minimum of five leading pharmaceutical firms. On the other hand, if the CMA does not announce the conclusion of this investigation by the given date, the inquiry will be considered FALSE.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "2dc71926-d6f7-48b1-8423-230c3cd6ff75", "title": "Is it possible that the CMA will not reveal the results of a significant investigation regarding drug pricing before July 2024?", "body": "This question will be deemed TRUE if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) fails to provide an official statement about the conclusion of its investigation into the pricing practices of at least five major pharmaceutical companies. Conversely, if the CMA does release the findings of this investigation by that date, the question will be labeled FALSE.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}]}}}]}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "840d08ba-1b13-4339-a4e1-9716182fb228", "title": "Will the CMA announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK officially announces the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. If the CMA does not announce the completion of such an investigation by this date, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.49958037655747317, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.42448507482821896, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.6377578334439237, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.65, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "f6ae63f3-c03c-4dcf-a93b-e9c835d43008", "title": "Will the CMA not announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK does not officially announce the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. If the CMA does announce the completion of such an investigation by this date, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "81727c81-a647-48f2-b164-19d177ea3b6d", "title": "Is it expected that the CMA will declare the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be considered as resolved in the affirmative if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) makes an official statement regarding the conclusion of its investigation into pricing practices in the pharmaceutical sector involving a minimum of five major firms. Conversely, if the CMA fails to make such an announcement by this deadline, the inquiry will be resolved in the negative.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "0fb4efe6-31b5-43cf-b21b-058b2f32c98e", "title": "Will the CMA not announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK does not officially announce the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. If the CMA announces the completion of such an investigation by this date, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.576767997638424, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.65, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "3ba54569-0f5a-45b2-b7b0-f21a336cc561", "title": "Will the CMA announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK officially announces the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. If the CMA does not announce the completion of such an investigation by this date, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "e0564dde-fc2f-45b4-9276-a49e882eb173", "title": "Is it possible that the CMA will refrain from declaring the conclusion of a significant inquiry into pharmaceutical pricing before July 2024?", "body": "This inquiry will be answered with a YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK has not made an official declaration regarding the conclusion of its investigation into the pricing practices of at least five major pharmaceutical firms. Conversely, if the CMA does announce the end of such an investigation by this deadline, the response will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "c1947e6d-1cf9-4ca7-a9b5-455db922b4a0", "title": "Will the CMA declare the conclusion of a significant inquiry into pharmaceutical pricing before July 2024?", "body": "This question will be answered with YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) makes an official statement regarding the conclusion of its investigation into the pricing practices of at least five major pharmaceutical companies. If the CMA fails to make such an announcement by this deadline, the answer will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3236956066164981, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "83f6ef78-33d9-468f-abe4-06172e194385", "title": "Will the CMA not declare the conclusion of a significant inquiry into pharmaceutical pricing before July 2024?", "body": "This question will be answered with YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) does not make an official statement regarding the conclusion of its investigation into the pricing practices of at least five major pharmaceutical companies. If the CMA makes such an announcement by this deadline, the answer will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.7, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "a46798b7-2e6d-4847-bc41-d6581fae5533", "title": "Is it possible that the CMA will announce the end of a major investigation into drug pricing prior to July 2024?", "body": "This inquiry will receive a YES response if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) releases a formal communication regarding the completion of its probe into the pricing strategies of a minimum of five leading pharmaceutical firms. Conversely, if the CMA does not issue such a declaration by this date, the response will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3, "elicitation_metadata": null}}}]}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "b4286394-1751-4769-a8cc-4caabbf1fb9e", "title": "Will the CMA not announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK does not officially announce the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. If the CMA announces the completion of such an investigation by this date, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3848841299781636, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.33631152003358045, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "9b7c5c53-de4d-405f-8215-56fe67cccc11", "title": "Will the CMA announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK officially announces the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. If the CMA does not announce the completion of such an investigation by this date, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "b66b739a-f043-4f2e-8527-eea320adc014", "title": "Will the CMA fail to declare the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK has not formally declared the conclusion of its investigation into the pricing practices of at least five major pharmaceutical companies. Conversely, if the CMA does announce the conclusion of such an investigation by this deadline, the inquiry resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3, "elicitation_metadata": null}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "7268920a-4c88-4af6-a44f-01122ec23ca5", "title": "Will the CMA announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK officially announces the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. If the CMA does not announce the completion of such an investigation by this date, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.5408715280421903, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.65, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "499c9e26-929b-4318-8c79-8e4301fcdfc7", "title": "Will the CMA not announce completion of a major pharmaceutical pricing investigation by July 2024?", "body": "This question resolves as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) of the UK does not officially announce the completion of its investigation into pharmaceutical pricing practices involving at least five major companies. If the CMA does announce the completion of such an investigation by this date, the question resolves as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "0e5a3381-779d-4f43-a257-ef699bf1852e", "title": "Is it expected that the CMA will declare the conclusion of a significant inquiry into pharmaceutical pricing before July 2024?", "body": "This question will be answered with YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) makes an official statement regarding the conclusion of its investigation into the pricing practices of at least five major pharmaceutical companies. Conversely, if there is no announcement about the completion of this investigation by that date, the answer will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "197ded04-366d-4aa7-a83f-5e29597e7f42", "title": "Is it possible that the CMA will refrain from declaring the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be answered with a YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) has not publicly declared the conclusion of its investigation into the pricing practices of at least five major pharmaceutical companies. Conversely, if the CMA does announce the conclusion of this investigation by that date, the answer will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3738059964439664, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "60f6322c-05af-4b8e-9956-b3bc671ec959", "title": "Is it not possible that the CMA will refrain from declaring the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be answered with a YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) has publicly declared the conclusion of its investigation into the pricing practices of at least five major pharmaceutical companies. Conversely, if the CMA does not announce the conclusion of this investigation by that date, the answer will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.7, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "a002c7c9-4233-4fd7-a5d2-f8ea7907d1c7", "title": "Could the CMA choose not to announce the findings of a major investigation into drug pricing before July 2024?", "body": "This inquiry will receive a YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) has not made a public announcement regarding the outcome of its investigation into the pricing strategies of at least five leading pharmaceutical firms. On the other hand, if the CMA does release the results of this investigation by that deadline, the answer will be NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}]}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "2bafa342-8773-4be2-a25d-911ecd0f52d4", "title": "Is it expected that the CMA will declare the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be deemed TRUE if, by July 31, 2024, the UK Competition and Markets Authority (CMA) makes an official statement regarding the end of its investigation into pricing practices in the pharmaceutical sector involving a minimum of five major firms. Conversely, if there is no announcement from the CMA regarding the conclusion of such an investigation by this date, the inquiry will be considered FALSE.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.47861380755978267, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.5627806530671691, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.65, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "2f5b99c5-87c0-40d9-9e55-7e08e0859119", "title": "Is it expected that the CMA will not declare the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be deemed TRUE if, by July 31, 2024, the UK Competition and Markets Authority (CMA) does not make an official statement regarding the end of its investigation into pricing practices in the pharmaceutical sector involving a minimum of five major firms. Conversely, if there is an announcement from the CMA regarding the conclusion of such an investigation by this date, the inquiry will be considered FALSE.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.7, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "fb4db3f0-6fd5-4e0e-a4a9-30e515bbe47a", "title": "Will the CMA announce the completion of a major investigation into drug pricing before July 2024?", "body": "This investigation will be classified as TRUE if, by July 31, 2024, the UK Competition and Markets Authority (CMA) issues a formal declaration about the conclusion of its probe into pricing practices within the pharmaceutical industry that involves at least five significant companies. On the other hand, if the CMA does not provide any statement concerning the end of such an investigation by this deadline, the inquiry will be marked as FALSE.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "52ec3fd9-2e31-441c-ade2-e7b23d815558", "title": "Is it expected that the CMA will not declare the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be deemed TRUE if, by July 31, 2024, the UK Competition and Markets Authority (CMA) does not make an official statement regarding the end of its investigation into pricing practices in the pharmaceutical sector involving a minimum of five major firms. Conversely, if there is an announcement from the CMA regarding the conclusion of such an investigation by this date, the inquiry will be considered FALSE.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.6179163652450348, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.7, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "61125b52-dfce-4726-b9f2-a064cfe48a77", "title": "Is it expected that the CMA will declare the conclusion of a significant inquiry into pharmaceutical pricing by July 2024?", "body": "This inquiry will be deemed TRUE if, by July 31, 2024, the UK Competition and Markets Authority (CMA) makes an official statement regarding the end of its investigation into pricing practices in the pharmaceutical sector involving a minimum of five major firms. Conversely, if there is no announcement from the CMA regarding the conclusion of such an investigation by this date, the inquiry will be considered FALSE.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "5e4459fd-795d-4bf8-89f2-0d801e293b9b", "title": "Will the CMA likely refrain from announcing the results of a major investigation into drug pricing before July 2024?", "body": "This inquiry will be regarded as TRUE if, by July 31, 2024, the UK Competition and Markets Authority (CMA) fails to release an official update concerning the conclusion of its probe into pricing practices within the pharmaceutical industry involving at least five major companies. On the other hand, if the CMA issues a statement about the end of such an investigation by this date, the inquiry will be classified as FALSE.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.7, "elicitation_metadata": null}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "3f8b4669-18a8-4241-a73a-4ec9d13cdd97", "title": "Will the CMA announce the results of a major investigation into drug pricing before July 2024?", "body": "This investigation will be classified as TRUE if the UK Competition and Markets Authority (CMA) issues an official communication about the completion of its review of pricing strategies in the pharmaceutical industry involving at least five leading companies by July 31, 2024. If the CMA does not provide any announcement concerning the conclusion of this investigation by that date, the inquiry will be regarded as FALSE.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.48573770432398344, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.65, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "dea58f91-9f8c-4516-ae13-a2a4d7536d1b", "title": "Will the CMA not announce the results of a major investigation into drug pricing before July 2024?", "body": "This investigation will be classified as TRUE if the UK Competition and Markets Authority (CMA) does not issue an official communication about the completion of its review of pricing strategies in the pharmaceutical industry involving at least five leading companies by July 31, 2024. If the CMA provides any announcement concerning the conclusion of this investigation by that date, the inquiry will be regarded as FALSE.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "762066b7-bbf0-4aa2-9386-6e71d9f14212", "title": "Is it possible that the CMA will reveal the findings of a significant inquiry into medication pricing prior to July 2024?", "body": "This inquiry will be deemed TRUE if the UK Competition and Markets Authority (CMA) makes an official statement regarding the finalization of its assessment of pricing practices in the pharmaceutical sector involving no fewer than five major companies by July 31, 2024. Conversely, if the CMA fails to make any announcement regarding the conclusion of this inquiry by that date, it will be considered FALSE.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3, "elicitation_metadata": null}}}]}}}]}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "d7fa9d36-8cb5-47ff-9126-d319e511deef", "title": "Will the CMA refrain from declaring the conclusion of a significant pharmaceutical pricing inquiry by July 2024?", "body": "This inquiry will be resolved as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK does not publicly declare that it has completed its investigation into the pricing practices of at least five major pharmaceutical companies. Conversely, if the CMA does announce the conclusion of this investigation by that date, the inquiry will be resolved as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.5235806059990668, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4866547890342251, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4494897427831781, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.65, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "75785a9d-d90d-4b04-bbec-6f588a7f0802", "title": "Will the CMA declare the conclusion of a significant pharmaceutical pricing inquiry by July 2024?", "body": "This inquiry will be resolved as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK publicly declares that it has completed its investigation into the pricing practices of at least five major pharmaceutical companies. Conversely, if the CMA does not announce the conclusion of this investigation by that date, the inquiry will be resolved as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "8c661d50-f4ea-455f-bbb9-88317f97ef0e", "title": "Will the CMA choose not to announce the outcome of a major pharmaceutical pricing investigation by July 2024?", "body": "This inquiry will be determined as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK fails to publicly state that it has finished its examination of the pricing strategies of a minimum of five leading pharmaceutical firms. On the other hand, if the CMA does make a public announcement regarding the conclusion of this investigation by that date, the inquiry will be determined as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "32a8dc44-6ac1-4c30-8a47-01abcb670542", "title": "Will the CMA declare the conclusion of a significant pharmaceutical pricing inquiry by July 2024?", "body": "This inquiry will be resolved as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK publicly declares that it has completed its investigation into the pricing practices of at least five major pharmaceutical companies. Conversely, if the CMA does not announce the conclusion of this investigation by that date, the inquiry will be resolved as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.576767997638424, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.65, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "044d4508-6df9-4ffb-b09b-bdf0bd8a4330", "title": "Will the CMA not declare the conclusion of a significant pharmaceutical pricing inquiry by July 2024?", "body": "This inquiry will be resolved as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK does not publicly declare that it has completed its investigation into the pricing practices of at least five major pharmaceutical companies. Conversely, if the CMA does announce the conclusion of this investigation by that date, the inquiry will be resolved as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "254daf36-1437-4af7-9c01-7f90d1b116bb", "title": "Will the CMA announce the completion of a major investigation into pharmaceutical pricing by July 2024?", "body": "This inquiry will be considered a YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK makes a public statement indicating that it has finalized its investigation into the pricing strategies of at least five leading pharmaceutical firms. On the other hand, if the CMA fails to make such an announcement by that deadline, the inquiry will be deemed a NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "49c88f4d-6343-4f51-8bd0-8f5227e5724f", "title": "Will the CMA hold off on announcing the outcome of a major pharmaceutical pricing investigation before July 2024?", "body": "This inquiry will be considered a YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK does not make a public statement about having finished its investigation into the pricing strategies of at least five leading pharmaceutical firms. On the other hand, if the CMA does reveal the completion of this investigation by that date, the inquiry will be deemed a NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.5372655245453061, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.6, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "f34c88f6-1e1b-4900-a5f0-1ce344844ceb", "title": "Will the CMA announce the outcome of a major pharmaceutical pricing investigation before July 2024?", "body": "This inquiry will be considered a YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK makes a public statement about having finished its investigation into the pricing strategies of at least five leading pharmaceutical firms. On the other hand, if the CMA does not reveal the completion of this investigation by that date, the inquiry will be deemed a NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "136cea25-4b38-4ea5-a814-580d6a9fe585", "title": "Will the CMA delay the disclosure of the results from a significant investigation into pharmaceutical pricing until after July 2024?", "body": "This question will be answered with a YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK has not publicly announced the conclusion of its investigation into the pricing practices of at least five major pharmaceutical companies. Conversely, if the CMA does announce the conclusion of this investigation by that date, the response will be a NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.6, "elicitation_metadata": null}}}]}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "0984983f-999c-45be-87f3-01e9d514cdd6", "title": "Will the CMA declare the conclusion of a significant pharmaceutical pricing inquiry by July 2024?", "body": "This inquiry will be resolved as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK publicly declares that it has completed its investigation into the pricing practices of at least five major pharmaceutical companies. Conversely, if the CMA does not announce the conclusion of this investigation by that date, the inquiry will be resolved as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.5860772260593133, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.4724134958845909, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.6, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "79c3ef0c-8a0f-4e1a-a549-a0f8a2e0829b", "title": "Will the CMA not declare the conclusion of a significant pharmaceutical pricing inquiry by July 2024?", "body": "This inquiry will be resolved as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK does not publicly declare that it has completed its investigation into the pricing practices of at least five major pharmaceutical companies. Conversely, if the CMA does announce the conclusion of this investigation by that date, the inquiry will be resolved as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "14917c69-9812-493f-884c-6fdcd0a4feb0", "title": "Is it possible that the CMA will announce the end of a major investigation into pharmaceutical pricing by July 2024?", "body": "This inquiry will be considered a YES if, by July 31, 2024, the UK's Competition and Markets Authority (CMA) publicly states that it has finalized its investigation into the pricing strategies of a minimum of five leading pharmaceutical firms. If, however, the CMA fails to make such an announcement by that date, the inquiry will be deemed a NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3, "elicitation_metadata": null}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "a80ccba7-79d4-45f9-bb2d-bc1733f54217", "title": "Will the CMA not declare the conclusion of a significant pharmaceutical pricing inquiry by July 2024?", "body": "This inquiry will be resolved as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK does not publicly declare that it has completed its investigation into the pricing practices of at least five major pharmaceutical companies. Conversely, if the CMA does announce the conclusion of this investigation by that date, the inquiry will be resolved as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4627344754546939, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.65, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "826d34cb-61b6-4c5a-b60f-d37926bf8fa7", "title": "Will the CMA declare the conclusion of a significant pharmaceutical pricing inquiry by July 2024?", "body": "This inquiry will be resolved as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK publicly declares that it has completed its investigation into the pricing practices of at least five major pharmaceutical companies. Conversely, if the CMA does not announce the conclusion of this investigation by that date, the inquiry will be resolved as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.6, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "fff20dd9-b560-4012-9ee0-5ea36ff99948", "title": "Will the CMA refrain from announcing the outcome of a major pharmaceutical pricing investigation before July 2024?", "body": "This investigation will be considered as resolved with a YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK has not made a public statement regarding the completion of its probe into the pricing strategies of at least five leading pharmaceutical firms. On the other hand, if the CMA does declare the conclusion of this investigation by that date, it will be resolved with a NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "6fb33d6b-47a9-476d-b57d-9926de4d5e35", "title": "Will the CMA announce the completion of a major pharmaceutical pricing investigation by the end of July 2024?", "body": "This investigation will be considered resolved as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK publicly states that it has finished its examination of the pricing practices of at least five leading pharmaceutical firms. On the other hand, if the CMA fails to make such an announcement by that deadline, the inquiry will be deemed NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.6628685678732142, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.65, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "eaabe3ad-d47b-4d0d-9892-6f9da6a2c7e6", "title": "Will the CMA not announce the completion of a major pharmaceutical pricing investigation by the end of July 2024?", "body": "This investigation will be considered resolved as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK publicly states that it has not finished its examination of the pricing practices of at least five leading pharmaceutical firms. On the other hand, if the CMA makes such an announcement by that deadline, the inquiry will be deemed NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.3, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "cd519455-46b9-44ad-b803-71b4845327d8", "title": "Is it expected that the CMA will declare the conclusion of a significant investigation into pharmaceutical pricing by the close of July 2024?", "body": "This inquiry will be marked as YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK officially announces that it has completed its review of the pricing strategies of at least five major pharmaceutical companies. Conversely, if the CMA does not issue such a statement by that date, the investigation will be classified as NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}]}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "5b1026a4-7b85-42af-95a1-4ead426c4e21", "title": "Will the CMA hold off on announcing the outcome of a major pharmaceutical pricing investigation before July 2024?", "body": "This inquiry will be deemed a YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK has not made a public statement regarding the completion of its investigation into the pricing strategies of a minimum of five leading pharmaceutical firms. On the other hand, if the CMA does declare the end of this investigation by that date, the inquiry will be considered a NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.5961304840162611, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.5636837589272705, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.6, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "e8e626f9-ac7c-43cc-9d34-0c91cd9b2638", "title": "Will the CMA announce the outcome of a major pharmaceutical pricing investigation before July 2024?", "body": "This inquiry will be deemed a YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK has made a public statement regarding the completion of its investigation into the pricing strategies of a minimum of five leading pharmaceutical firms. On the other hand, if the CMA does not declare the end of this investigation by that date, the inquiry will be considered a NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "71fc12a2-a85f-4c33-bf7b-3c6095c1845a", "title": "Will the CMA delay revealing the results of a significant pharmaceutical pricing probe until after July 2024?", "body": "This question will be answered with a YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK has not issued any public announcement concerning the conclusion of its investigation into the pricing tactics of at least five major pharmaceutical companies. Conversely, if the CMA announces the conclusion of this investigation by that date, the answer will be regarded as a NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}]}, {"name": "NegChecker", "data": {"not_P": {"id": "9a6e5b77-3f67-47e5-96db-7803bb1c3daf", "title": "Will the CMA announce the outcome of a major pharmaceutical pricing investigation before July 2024?", "body": "This inquiry will be deemed a YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK has made a public statement regarding the completion of its investigation into the pricing strategies of a minimum of five leading pharmaceutical firms. On the other hand, if the CMA does not declare the end of this investigation by that date, the inquiry will be considered a NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.576767997638424, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.65, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "04d57693-fc03-4bfc-9417-2b74164e2fd4", "title": "Will the CMA not announce the outcome of a major pharmaceutical pricing investigation before July 2024?", "body": "This inquiry will be deemed a YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK has not made a public statement regarding the completion of its investigation into the pricing strategies of a minimum of five leading pharmaceutical firms. On the other hand, if the CMA does declare the end of this investigation by that date, the inquiry will be considered a NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "1e813181-dcc7-4a39-9319-bad9ad192f9d", "title": "Will the CMA reveal the results of a significant investigation into pharmaceutical pricing prior to July 2024?", "body": "This question will be answered with a YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK has issued a public announcement concerning the conclusion of its inquiry into the pricing practices of at least five major pharmaceutical companies. Conversely, if the CMA fails to announce the conclusion of this inquiry by that date, the response will be a NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.65, "elicitation_metadata": null}}}]}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "2c437c3b-6cd9-452e-83ae-cc4109e2b57e", "title": "Will the CMA delay revealing the results of a significant pharmaceutical pricing probe until after July 2024?", "body": "This investigation will be classified as a YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK has not issued a public announcement about the conclusion of its investigation into the pricing tactics of at least five major pharmaceutical companies. Conversely, if the CMA does announce the completion of this investigation by that date, the inquiry will be regarded as a NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.6911352856139561, "elicitation_metadata": [{"name": "P", "elicited_prob": 0.65, "elicitation_metadata": null}, {"name": "NegChecker", "data": {"not_P": {"id": "432b02df-225d-45bd-bbfb-9b2684d2977e", "title": "Will the CMA not delay revealing the results of a significant pharmaceutical pricing probe until after July 2024?", "body": "This investigation will be classified as a YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK has issued a public announcement about the conclusion of its investigation into the pricing tactics of at least five major pharmaceutical companies. Conversely, if the CMA does not announce the completion of this investigation by that date, the inquiry will be regarded as a NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.4, "elicitation_metadata": null}}}, {"name": "ParaphraseChecker", "data": {"para_P": {"id": "972bec31-bbe4-48e5-ad82-db13b9e75132", "title": "Is the CMA expected to postpone the announcement of the findings from a major investigation into pharmaceutical pricing until after July 2024?", "body": "This inquiry will be deemed a YES if, by July 31, 2024, the Competition and Markets Authority (CMA) in the UK has not made a public statement regarding the outcome of its investigation into the pricing strategies of at least five leading pharmaceutical firms. On the other hand, if the CMA does reveal the results of this investigation by that date, it will be classified as a NO.", "resolution_date": "2024-07-31 23:59:59+00:00", "question_type": "binary", "data_source": "synthetic_inst", "created_date": "2024-06-30 23:59:59+00:00", "url": null, "metadata": null, "resolution": null, "elicited_prob": 0.75, "elicitation_metadata": null}}}]}}}]}}}]}}}]}}}, "violation_data": {"default": {"metric": "default", "violation": 0.0009025753959908123, "check": true, "check_result": "Passed", "successful_elicitation": true}, "default_scaled": {"metric": "default_scaled", "violation": 0.00045128769799540613, "check": true, "check_result": "Passed", "successful_elicitation": true}, "frequentist": {"metric": "frequentist", "violation": 0.042454151902949204, "check": true, "check_result": "Passed", "successful_elicitation": true}}}
